Mölnlycke Health Care publishes Annual report for 2024

“Our strong financial position and continued growth allow us to direct our future and continued investments. At the same time, it is clear that our strategy and previous investments have paid off, enabling close relationships with our customers working alongside them to handle the challenges of healthcare today,” says Zlatko Rihter, CEO of Mölnlycke.

Highlights from the year:

• Continued strong growth at 7.4% compared to previous year and annual sales of EUR 2,064 million with improved profitability.
• The progress in becoming a leader in sustainable healthcare was recognised with a platinum medal from EcoVadis.
• Focus on transformation through partnerships commenced in 2024 with the acquisition of P.G.F. Industry Solutions, the strategic partnership with Ondine Biomedical Inc and strategic investments in MediWound and Siren. The joint venture Tamer Mölnlycke Care in Saudi Arabia has started production and there are plans for expansion in India and China.

Download and read the full report on www.molnlycke.com/corporate/about/reports

For more information, please contact: 

Jamie Smith

Media Relations

Email: jamie.smith@molnlycke.com

Phone: +46 723 757507